TWiPO #97: GD2-CAR T Cell Therapy for H3K27M-mutated Diffuse Midline Gliomas with Dr. Robbie Majzner
Play • 26 min

WATCH THE VIDEO WEBCAST HERE: https://youtu.be/5TYFsjh91Tw

Listen in as our host, Dr. Brenda Weigel from the University of Minnesota, is joined by Dr. Robbie Majzner - an Assistant Professor of Pediatrics in the Division of Hematology and Oncology at Stanford University's School of Medicine. Dr. Majzner goes into great detail about his recent clinical trial on GD2-CAR T cell therapy for H3K27M-mutated Diffuse Midline Gliomas - the findings, the process, and what the future holds. You can read more about Dr. Majzner's study here: https://www.nature.com/articles/s41586-022-04489-4

Have any thoughts? Questions? Ideas for future topics? Email us at TWIPO@solvingkidscancer.org.

Subscribe to TWIPO to get notifications of new uploads.

Want to listen to TWIPO's past episodes? Visit www.solvingkidscancer.org/podcast

More episodes
Search
Clear search
Close search
Google apps
Main menu